EDGAR Filing Documents for 0001213900-20-016181

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-20-016181

Filing Date

2020-06-29

Accepted

2020-06-29 18:48:43

Documents

116

Period of Report

2020-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2020_elitepharma.htm	10-K	1419974
2	DESCRIPTION OF COMMON STOCK	f10k2020ex4-6_elite.htm	EX-4.6	24779
3	EMPLOYMENT AGREEMENT WITH DOUGLAS PLASSCHE	f10k2020ex10-52_elite.htm	EX-10.52	22968
4	JUNE 21, 2019 RETENTION AGREEMENT WITH DOUGLAS PLASSCHE	f10k2020ex10-53_elite.htm	EX-10.53	11937
5	JULY 29, 2019 AMENDMENT TO THE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT BETWEE	f10k2020ex10-54_elite.htm	EX-10.54	47108
6	CONSENTOF BUCHBINDER TUNICK & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNT	f10k2020ex23-1_elite.htm	EX-23.1	2418
7	CERTIFICATION	f10k2020ex31-1_elite.htm	EX-31.1	16399
8	CERTIFICATION	f10k2020ex31-2_elite.htm	EX-31.2	15691
9	CERTIFICATION	f10k2020ex32-1_elite.htm	EX-32.1	6247
10	CERTIFICATION	f10k2020ex32-2_elite.htm	EX-32.2	6103
11	GRAPHIC	ex10-2_001.jpg	GRAPHIC	9087
12	GRAPHIC	ex10-52_001.jpg	GRAPHIC	43219
	Complete submission text file	0001213900-20-016181.txt		6410636

Data Files

Seq	Description	Document	Type	Size
13	XBRL INSTANCE FILE	eltp-20200331.xml	EX-101.INS	920726
14	XBRL SCHEMA FILE	eltp-20200331.xsd	EX-101.SCH	92402
15	XBRL CALCULATION FILE	eltp-20200331_cal.xml	EX-101.CAL	77879
16	XBRL DEFINITION FILE	eltp-20200331_def.xml	EX-101.DEF	283457
17	XBRL LABEL FILE	eltp-20200331_lab.xml	EX-101.LAB	526463
18	XBRL PRESENTATION FILE	eltp-20200331_pre.xml	EX-101.PRE	433715

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)